Ruzinurad is a highly selective URATl inhibitor (WO2020088641, compound I). Ruzinurad can be used in the study of hyperuricemia.

Ruzinurad is a highly selective URATl inhibitor[1].

1638327-48-6

C14H12BrNO2S

338.22

Ruzinurad

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years